IHT Wealth Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
Other funds holding GNOM
OAM
USCWA
SWP
AA
CFD
IHT Wealth Management's GNOM Position: Q1 2026 in Review
IHT Wealth Management sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q1 2026, closing a stake of 18,090 shares — an estimated $822K sold.
IHT Wealth Management first reported a position in GNOM in Q1 2022 and held it in 16 quarters. The position peaked at $1.14M in Q1 2024. 40 funds tracked by Wall St. Rank hold GNOM as of Q1 2026.
- IHT Wealth Management reported no remaining Global X Genomics & Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
- IHT Wealth Management sold 18,090 Global X Genomics & Biotechnology ETF shares in Q1 2026, an estimated $822K.
- IHT Wealth Management first reported a position in Global X Genomics & Biotechnology ETF in Q1 2022 and held it in 16 quarters.
- IHT Wealth Management's Global X Genomics & Biotechnology ETF position peaked at $1.14M in Q1 2024.
- 40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2026.
Based on IHT Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.